Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07218731 · ClinicalTrials.gov registry record · NA
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
A NA study of Presbyopia and Presbyopia Correction, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07218731: Recruiting NA study of Presbyopia and Presbyopia Correction, sponsored by Ohio State University.
NCT07218731 is a NA study of Presbyopia and Presbyopia Correction that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 30 participants, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07218731, a NA study of Presbyopia and Presbyopia Correction, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to assess participant experience when wearing multifocal contact lenses compared to spherical contact lenses with reading glasses.
Primary Outcome
Percentage of participants who prefer the multifocal lenses compared to spherical lenses with reading glasses.
Conditions Studied
Interventions
- DEVICE Multifocal contact lenses
- DEVICE Spherical contact lenses
Study Locations (1)
Ohio
- The Ohio State University College of Optometry - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-12-08 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT07218731 shows while recruiting
NCT07218731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which Multifocal contact lenses is the first listed.
NCT07218731 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07218731 about?
NCT07218731 is a clinical study titled "Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses". The purpose of the study is to assess participant experience when wearing multifocal contact lenses compared to spherical contact lenses with reading glasses.
What is the current status of trial NCT07218731?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-12-08. Estimated completion is 2026-06.
What conditions does trial NCT07218731 study?
This clinical trial studies the following conditions: Presbyopia, Presbyopia Correction.
What interventions are being tested in trial NCT07218731?
The interventions under investigation include: Multifocal contact lenses (DEVICE), Spherical contact lenses (DEVICE).
Who is sponsoring clinical trial NCT07218731?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07218731 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07218731's enrollment target sits among peer trials
30 34th of 38 higher than 5 of 38 other Presbyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Presbyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
-
A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI